Simo Du

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Fellow

UAMS

Also affiliated: Albert Einstein College of Medicine (2025–2026); Johns Hopkins University (2019–2024); University of Illinois Urbana-Champaign (2026); University of Arkansas Medical Center (2026); Jacobi Medical Center (2025–2026); Chinese University of Hong Kong, Shenzhen (2026)

6 h-index 70 pubs 474 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Simo Du's research investigates health disparities and outcomes, particularly focusing on the impact of societal events and conditions on patient experiences and health status. His work includes examining the association of the COVID-19 pandemic with deficits in cancer screening and delays in diagnosis and treatment, as well as exploring the use of telemedicine among cancer patients across different socioeconomic groups. Du has also studied the long-term relationship between cigarette smoking patterns and hearing impairment, and the connection between longitudinal blood pressure patterns and late-life hearing loss within the Atherosclerosis Risk in Communities Study. His research also touches on multilevel determinants of co-occurring health issues, including violence, HIV, mental health, and substance use. With an h-index of 6 and 65 total publications, Du's scholarship contributes to understanding complex health challenges and access to care.

Metrics

h-index: 6
Publications: 70
Citations: 474

Positions

Johns Hopkins University publications 2019–2024

ORCID
Fellow publications 2026

University of Arkansas for Medical Sciences Institution web page

Selected Publications

MM-1667: Early-Onset Plasmacytoma: A National Cancer Database Analysis of Clinical Features, Treatment Patterns, and Survival (2026)

Clinical Lymphoma Myeloma & Leukemia DOI OpenAlex
MM-1315: Beyond a Single Entity: Site-Specific Heterogeneity in Clinical Characteristics, Treatment Patterns, and Survival Outcomes Among Patients With Plasmacytoma (2026)

Clinical Lymphoma Myeloma & Leukemia DOI OpenAlex
CT-1487: Trends and Disparities in CAR-T Therapy Utilization, Inpatient Mortality, Length of Stay, and Costs in the United States (2017–2022) (2026)

Clinical Lymphoma Myeloma & Leukemia DOI OpenAlex
Trends and Disparities in Chimeric Antigen Receptor T-Cell Therapy Utilization, Inpatient Mortality, Length of Stay, and Costs in the United States (2017 to 2022) (2026)

Transplantation and Cellular Therapy DOI OpenAlex